JPWO2022137357A1 - - Google Patents

Info

Publication number
JPWO2022137357A1
JPWO2022137357A1 JP2022523975A JP2022523975A JPWO2022137357A1 JP WO2022137357 A1 JPWO2022137357 A1 JP WO2022137357A1 JP 2022523975 A JP2022523975 A JP 2022523975A JP 2022523975 A JP2022523975 A JP 2022523975A JP WO2022137357 A1 JPWO2022137357 A1 JP WO2022137357A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022523975A
Other languages
Japanese (ja)
Other versions
JPWO2022137357A5 (https=
JP7166039B1 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022137357A1 publication Critical patent/JPWO2022137357A1/ja
Priority to JP2022166686A priority Critical patent/JP2023002665A/ja
Application granted granted Critical
Publication of JP7166039B1 publication Critical patent/JP7166039B1/ja
Publication of JPWO2022137357A5 publication Critical patent/JPWO2022137357A5/ja
Priority to JP2023178978A priority patent/JP7719520B2/ja
Priority to JP2023178979A priority patent/JP7644527B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0819Tripeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
JP2022523975A 2020-12-22 2020-12-22 ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法 Active JP7166039B1 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2022166686A JP2023002665A (ja) 2020-12-22 2022-10-18 ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法
JP2023178978A JP7719520B2 (ja) 2020-12-22 2023-10-17 ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法
JP2023178979A JP7644527B2 (ja) 2020-12-22 2023-10-17 ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2020/048023 WO2022137357A1 (ja) 2020-12-22 2020-12-22 ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022166686A Division JP2023002665A (ja) 2020-12-22 2022-10-18 ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法

Publications (3)

Publication Number Publication Date
JPWO2022137357A1 true JPWO2022137357A1 (https=) 2022-06-30
JP7166039B1 JP7166039B1 (ja) 2022-11-07
JPWO2022137357A5 JPWO2022137357A5 (https=) 2022-12-05

Family

ID=82159226

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2022523975A Active JP7166039B1 (ja) 2020-12-22 2020-12-22 ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法
JP2022166686A Pending JP2023002665A (ja) 2020-12-22 2022-10-18 ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法
JP2023178979A Active JP7644527B2 (ja) 2020-12-22 2023-10-17 ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法
JP2023178978A Active JP7719520B2 (ja) 2020-12-22 2023-10-17 ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2022166686A Pending JP2023002665A (ja) 2020-12-22 2022-10-18 ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法
JP2023178979A Active JP7644527B2 (ja) 2020-12-22 2023-10-17 ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法
JP2023178978A Active JP7719520B2 (ja) 2020-12-22 2023-10-17 ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法

Country Status (4)

Country Link
US (1) US20240101599A1 (https=)
JP (4) JP7166039B1 (https=)
KR (1) KR20230124607A (https=)
WO (1) WO2022137357A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025215720A1 (ja) * 2024-04-09 2025-10-16 株式会社マルハチ村松 タンパク質産生促進剤、該タンパク質産生促進剤を含む培地、及び、該タンパク質産生促進剤を用いたタンパク質産生促進方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537782B1 (en) 1998-06-01 2003-03-25 Chugai Seiyaku Kabushiki Kaisha Media for culturing animal cells and process for producing protein by using the same
WO2001046220A2 (en) * 1999-12-22 2001-06-28 Polymun Scientific Immunbiologische Forschung Gmbh Bioactive oligopeptides
JP2003137807A (ja) * 2001-11-01 2003-05-14 Miyagi Kagaku Kogyo Kk コラーゲン産生促進剤、それを含む化粧品、食品および医薬品ならびに皮膚疾患の予防または改善用外用剤
JP3822137B2 (ja) 2002-05-20 2006-09-13 中外製薬株式会社 動物細胞培養用培地の添加剤およびそれを用いたタンパク質の製造方法
JP2007051127A (ja) * 2005-07-22 2007-03-01 Sanyo Chem Ind Ltd 細胞接着性ポリペプチド
WO2007079977A2 (en) * 2006-01-16 2007-07-19 Dsm Ip Assets B.V. Nutraceutical compositions comprising tripeptides
SG10201803541TA (en) * 2007-09-05 2018-06-28 Genentech Inc Biologically active c-terminal arginine-containing peptides
US8252557B2 (en) * 2008-10-28 2012-08-28 Chugai Seiyaku Kabushiki Kaisha Peptide-containing culture medium for culturing animal cell
JP5664992B2 (ja) 2009-08-26 2015-02-04 国立大学法人名古屋大学 細胞特異的ペプチド及びその用途
JP5792442B2 (ja) 2010-09-01 2015-10-14 帝人株式会社 細胞特異的ペプチドを含有する繊維構造体
WO2018085565A2 (en) * 2016-11-03 2018-05-11 Helix Biomedix, Inc. Short bioactive peptides blocking activity of advanced glycation end products, compositions, and methods of use
CA3194377A1 (en) * 2020-10-02 2022-04-07 Corporation Genacol Canada Inc. Bioactive collagen peptides, method of production thereof, and use thereof

Also Published As

Publication number Publication date
KR20230124607A (ko) 2023-08-25
US20240101599A1 (en) 2024-03-28
JP2023002665A (ja) 2023-01-10
JP7719520B2 (ja) 2025-08-06
WO2022137357A1 (ja) 2022-06-30
JP7166039B1 (ja) 2022-11-07
JP7644527B2 (ja) 2025-03-12
JP2024009994A (ja) 2024-01-23
JP2024009995A (ja) 2024-01-23

Similar Documents

Publication Publication Date Title
JPWO2022137357A1 (https=)
CL2025003474A1 (es) Sales agonistas de sstr4.
CN306186858S (https=)
CN305810056S (https=)
CN306120288S (https=)
CN306112569S (https=)
CN306112235S (https=)
CN306108344S (https=)
CN306102117S (https=)
CN306098632S (https=)
CN306078838S (https=)
CN306070875S (https=)
CN306061390S (https=)
CN306061364S (https=)
CN306060572S (https=)
CN306024252S (https=)
CN305945103S (https=)
CN305943641S (https=)
CN305942662S (https=)
CN305536775S (https=)
CN305536735S (https=)
CN305535519S (https=)
CN305535307S (https=)
CN306179234S (https=)
CN305534774S (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220518

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220518

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20220518

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220719

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220920

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20221004

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20221018

R150 Certificate of patent or registration of utility model

Ref document number: 7166039

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250